Gyula Pados

Orlistat increases serum paraoxonase activity in obese patients

Mária Audikovszky, Gyula Pados, I. Serés et al. · Nutrition Metabolism and Cardiovascular Diseases · 2006 · 37 citations

Obesity, Metabolic Syndrome, Serum Paraoxonase Activity +4

Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome

György Paragh, I. Serés, Mariann Harangi et al. · British Journal of Clinical Pharmacology · 2006 · 25 citations · Full text

Lipid-Modifying Therapy and Attainment of Cholesterol Goals in Hungary

Gy. Paragh, L szlo M rk, K roly Z molyi et al. · Clinical Drug Investigation · 2007 · 21 citations

Cholesterol Goals, Nutrition, Metabolic Syndrome +8

Apolipoprotein E and Complement C3 Polymorphism and Their Role in the Response to Gemfibrozil and Low Fat Low Cholesterol Therapy

Attila Németh, Kati Szakmary, Judith M. Kramer et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 1995 · 20 citations · Full text

Changes in attainment of lipid goals by general practitioners and specialists in patients at high cardiovascular risk in Hungary during 2004-2008

László Márk, György Paragh, István Karádi et al. · Archives of Medical Science · 2010 · 16 citations · Full text